High Tower Advisors, LLC Akoya Biosciences, Inc. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 20,000 shares of AKYA stock, worth $25,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$25,800
Previous $45,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AKYA
# of Institutions
66Shares Held
12.5MCall Options Held
40.4KPut Options Held
1K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$6.06 Million6.47% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$1.79 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX671KShares$865,5902.35% of portfolio
-
Geode Capital Management, LLC Boston, MA567KShares$731,4060.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $48.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...